Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"

Mikhail Kosiborod; Matthew A Cavender; Alex Z Fu; John P Wilding; Kamlesh Khunti; Reinhard W Holl; Anna Norhammar; Kåre I Birkeland; Marit Eika Jørgensen; Marcus Thuresson; Niki Arya; Johan Bodegård; Niklas Hammar; Peter Fenici; CVD-REAL Investigators and Study Group

doi:10.1161/CIRCULATIONAHA.117.031847

Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"

Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson, Niki Arya, Johan Bodegård, Niklas Hammar, Peter Fenici, CVD-REAL Investigators and Study Group

Steno Diabetes Center Copenhagen

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Circulation (Baltimore)
Vol/bind	137
Udgave nummer	9
Sider (fra-til)	989-991
Antal sider	3
ISSN	0009-7322
DOI	https://doi.org/10.1161/CIRCULATIONAHA.117.031847
Status	Udgivet - 27 feb. 2018

Adgang til dokumentet

10.1161/CIRCULATIONAHA.117.031847

Citationsformater

Kosiborod, M., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K., Holl, R. W., Norhammar, A., Birkeland, K. I., Jørgensen, M. E., Thuresson, M., Arya, N., Bodegård, J., Hammar, N., Fenici, P., & CVD-REAL Investigators and Study Group (2018). Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". Circulation (Baltimore), 137(9), 989-991. https://doi.org/10.1161/CIRCULATIONAHA.117.031847

Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs : The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". / Kosiborod, Mikhail; Cavender, Matthew A; Fu, Alex Z et al.

I: Circulation (Baltimore), Bind 137, Nr. 9, 27.02.2018, s. 989-991.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Kosiborod, M, Cavender, MA, Fu, AZ, Wilding, JP, Khunti, K, Holl, RW, Norhammar, A, Birkeland, KI, Jørgensen, ME, Thuresson, M, Arya, N, Bodegård, J, Hammar, N, Fenici, P & CVD-REAL Investigators and Study Group 2018, 'Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"', Circulation (Baltimore), bind 137, nr. 9, s. 989-991. https://doi.org/10.1161/CIRCULATIONAHA.117.031847

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW et al. Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". Circulation (Baltimore). 2018 feb. 27;137(9):989-991. https://doi.org/10.1161/CIRCULATIONAHA.117.031847

Kosiborod, Mikhail ; Cavender, Matthew A ; Fu, Alex Z et al. / Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs : The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". I: Circulation (Baltimore). 2018 ; Bind 137, Nr. 9. s. 989-991.

@article{1b3a7890f8d6458397f24ead02bdbcc2,

title = "Response by Kosiborod et al to Letters Regarding Article, {"}Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors){"}",

keywords = "Letter",

author = "Mikhail Kosiborod and Cavender, {Matthew A} and Fu, {Alex Z} and Wilding, {John P} and Kamlesh Khunti and Holl, {Reinhard W} and Anna Norhammar and Birkeland, {K{\aa}re I} and J{\o}rgensen, {Marit Eika} and Marcus Thuresson and Niki Arya and Johan Bodeg{\aa}rd and Niklas Hammar and Peter Fenici and {CVD-REAL Investigators and Study Group}",

year = "2018",

month = feb,

day = "27",

doi = "10.1161/CIRCULATIONAHA.117.031847",

language = "English",

volume = "137",

pages = "989--991",

journal = "Circulation (Baltimore)",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "9",

}

TY - JOUR

T1 - Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

T2 - The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"

AU - Kosiborod, Mikhail

AU - Cavender, Matthew A

AU - Fu, Alex Z

AU - Wilding, John P

AU - Khunti, Kamlesh

AU - Holl, Reinhard W

AU - Norhammar, Anna

AU - Birkeland, Kåre I

AU - Jørgensen, Marit Eika

AU - Thuresson, Marcus

AU - Arya, Niki

AU - Bodegård, Johan

AU - Hammar, Niklas

AU - Fenici, Peter

AU - CVD-REAL Investigators and Study Group

PY - 2018/2/27

Y1 - 2018/2/27

KW - Letter

U2 - 10.1161/CIRCULATIONAHA.117.031847

DO - 10.1161/CIRCULATIONAHA.117.031847

M3 - Journal article

C2 - 29483180

VL - 137

SP - 989

EP - 991

JO - Circulation (Baltimore)

JF - Circulation (Baltimore)

SN - 0009-7322

IS - 9

ER -